addmedica Home Page
News
addmedica
Chairman's foreword
Team
Unmet medical needs and products
Job offers
Business opportunities
European network
Business development
Products
SIKLOS® (Hydroxycarbamide)
LUMIDERM® 6000
HYALOMATRIX® PA
PERFADEX®
STEEN Solution™
Login application form
Comments and questions?
Favorite links
Search
A memorial to Jean-Michel

addmedica Home Page

HomeLiens favorisContact-usWebsite map
adding value for health

a new actor in medical products for unmet medical needs in Europe
addmedica is a medical product company dedicated to adding innovative and personalized responses for patients who are among the 30 million people suffering from one of the 4,500 identified rare diseases in Europe. 
Currently, there are many unmet medical needs for medical products to be used together with, or instead of, drugs in niche markets or rare diseases.
Addressing this unique market requires a specific know-how and a dedicated European organisation.
more....

    Chairman's foreword

    addmedica, founded in 2005, is a European start-up focused on developing and marketing medical products for:
    rare diseases
    real unmet medical needs
    serious conditions
    more...

    Situation vacant

    Currently candidates are sought
    more...

    Marketed Products



    SIKLOS in Sickle Cell Disease
    : European Marketing Approval

    HYALOMATRIX®PA (France)
    Hyalomatrix®PA (i.e. " Prolonged Action ") is a bioresorbable dermal substitute made of HYAFF®, a long acting derivative of hyaluronic acid providing.... 
    more...

    LUMIDERM® 6000 (France)
    LUMIDERM® 6000 is a porous, semi-permeable, absorbent and highly conformable wound dressing consisting of a thin micro-porous polyurethane foam membrane...
    more...

    PERFADEX® in France
    Perfadex® is a colloid containing, lightly buffered ´extracellular´ low K+ electrolyte solution, used for rapid cooling, perfusion and storage of organs and tissues in connection with transplantation.
    more...

    STEEN SolutionTM (France)
    STEEN Solution™ is intended for assessment of isolated lungs after removal from the donor for eventual transplantation into a recipient.
    more...

    Mission and targeted products

    In Europe, there are more than 30 million "victims" of one of the 4,500 identified rare diseases.
    In most cases, the treatment of such patients requires the combination of drugs and medical products. As for orphan drugs, specific needs also exist for « orphan » medical products (devices, annex therapeutic products…)
    addmedica 's focuses on the market of medical products for treatment of rare diseases, metabolic disorders and genetic diseases where numerous unmet medical needs exist.
    more...


      Latest update: 2009 06 23


      News




      Contact us
      Headquarter:
      101 Rue Saint-Lazare
      F-75009 PARIS
      FRANCE

      Phone:
      +33  (0)172 690 186
      Fax: 
      +33 (0) 173 729 413


      © ADDMEDICA - adding value for health
      Legal Information